Clinical trial
Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate…
NCT00289913 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00289913 |
|---|---|
| Title | Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Given to Healthy Children 15 Months of Age (V251-068) |
| Official title | An Open, Randomized, Multicenter Study of the Safety, Tolerability, and Immunogenicity of VAQTA™ Given Concomitantly With PedvaxHIB™ and Infanrix™ in Healthy Children 15 Months of Age |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hepatitis A Virus |
| Intervention type | Biological |
| Interventions | Comparator: VAQTA™, Comparator: Infanrix™, Comparator: PedvaxHIB™ |
| Enrollment | 1,274 |
| Start date | Apr 1, 2006 |
| Primary completion | Jun 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | Feb 10, 2006 |
| Last update posted | Apr 13, 2017 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: